Search for: "WYETH PHARMACEUTICALS COMPANY" Results 361 - 380 of 547
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Mar 2010, 5:52 am by Kelly
Other companies include Pfizer, Dell and Wyeth. [read post]
27 Apr 2010, 4:30 am by Jim Dedman
For example, when the Court found no implied preemption in the pharmaceutical labeling case, Wyeth v. [read post]
27 Sep 2011, 2:31 pm by Jeff Klein
Wyeth followed suit, holding that state law failure-to-warn claims against generic pharmaceutical manufacturers were pre-empted by federal law. [read post]
12 Feb 2015, 12:56 pm
  It needed the pharmaceutical company-doctor-patient relationship to fit that mold. [read post]
13 Nov 2009, 12:45 pm
Perhaps unsurprisingly, it didn’t take long for the discussion to go off the rails, thanks to panel member Daniel Troy, Chief Counsel at the FDA from 2001 to 2004, who prior to that, represented pharmaceutical and tobacco companies in cases against the agency, and who ultimately became one of the major architects behind the whole cockamamie version of preemption which had federal agencies protecting industry from liability rather than the other way around, and… [read post]
7 Sep 2010, 6:10 pm by Kelly
Perrigo Co (IPBiz) Norvir (Ritonavir) – US: Abbott’s HIV/AIDS drug patents challenged by PUBPAT (IP Watchdog) ReFacto (Moroctocog) and Xyntha (Antihemophilic factor) – US: Novartis drops one of three patents from ReFacto/Xyntha suit against Wyeth (Patent Docs) Strattera (Atomoxetine) – US: CAFC grants injunction pending disposition of Lilly v Actavis Elizabeth (Patent Docs) Valcyte (Valganciclovir) – US: Ranbaxy settles patent dispute with Roche over Valcyte… [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol patent… [read post]
6 Oct 2010, 4:22 am by Kelly
General Update on the Indo-E.U. trade dispute before the WTO (Spicy IP) Australia: Proceedings in other jurisdictions no excuse for delay: Wyeth v The Kennedy Institute of Rheumatology (Patentology) EU: Positive opinions on Paediatric Investigation Plans (The SPC Blog) EU: Guidelines for biosimilar antibodies in Europe due in November (Patent Docs) Netherlands: Court of Appeal of The Hague dismisses request to suspend execution of judgment in first instance: Sandoz v Leo… [read post]
12 Oct 2010, 8:26 am by Joe Consumer
Pharmaceutical companies responded with a threat - they would stop making vaccines unless federal lawmakers shielded them from liability. [read post]
12 Oct 2010, 8:26 am by Joe Consumer
Pharmaceutical companies responded with a threat - they would stop making vaccines unless federal lawmakers shielded them from liability. [read post]
6 Jan 2007, 7:34 am
-based company was more than happy to "discover" the root's propensities. [read post]
9 Nov 2009, 6:01 am
Across the U.S., pharmaceutical companies have been pleading guilty to criminal charges or paying penalties in civil cases when the U.S. [read post]
9 May 2010, 5:15 am by Lawrence B. Ebert
Grassley, ask Wyeth and DesignWrite, a medical writing company [based in Princeton, NJ], to disclose payments related to the preparation of journal articles and the activities of doctors who were recruited to put their names on them for publication. [read post]
31 Jul 2018, 2:29 pm by Sarah Aberg and Bochan Kim
Martoma’s portfolio included two pharmaceutical companies, Elan Corporation, plc (“Elan”) and Wyeth Pharmaceuticals, Inc. [read post]
31 Jul 2018, 2:29 pm by Sarah Aberg and Bochan Kim
Martoma’s portfolio included two pharmaceutical companies, Elan Corporation, plc (“Elan”) and Wyeth Pharmaceuticals, Inc. [read post]